Lyles, J. L., Martin, L. J., Shoda, T., Collins, M. H., Trimarchi, M. P., He, H., … Rothenberg, M. E. (2021). Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. Journal of Allergy and Clinical Immunology, 147(1), 244-254.e6. https://doi.org/10.1016/j.jaci.2020.10.017

Lyles, John L., Lisa J. Martin, Tetsuo Shoda, Margaret H. Collins, Michael P. Trimarchi, Hua He, Leah C. Kottyan, Vincent A. Mukkada, and Marc E. Rothenberg. “Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants.” Journal of Allergy and Clinical Immunology 147, no. 1 (January 2021): 244-254.e6. https://doi.org/10.1016/j.jaci.2020.10.017.

Lyles JL, Martin LJ, Shoda T, Collins MH, Trimarchi MP, He H, et al. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. Journal of Allergy and Clinical Immunology. 2021 Jan;147(1):244-254.e6.

Lyles, John L., et al. “Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants.” Journal of Allergy and Clinical Immunology, vol. 147, no. 1, Elsevier BV, Jan. 2021, pp. 244-254.e6. Crossref, doi:10.1016/j.jaci.2020.10.017.

Lyles JL, Martin LJ, Shoda T, Collins MH, Trimarchi MP, He H, Kottyan LC, Mukkada VA, Rothenberg ME. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. Journal of Allergy and Clinical Immunology. Elsevier BV; 2021 Jan;147(1):244-254.e6.